fKnowledge, experience and skill are Ingredients in Everything We Make
Our Management Team
The WellSpring management team is passionate about one thing: providing pharmaceutical contract development, manufacturing and packaging services that will help you realize your product’s full potential. They bring experience in pharmaceutical manufacturing, packaging, quality assurance and quality control testing from some of the world’s largest CDMOs/CMOs and pharmaceutical companies. Committed to quality and customer service, they work continually to build on WellSpring's culture of integrity, trust and reliability.
With more than 20 years of business development and marketing experience in the pharmaceutical contract development and manufacturing industry, Sam Ricchezza has held a number of progressively responsible business development positions over the course of his career with Patheon, DPT Laboratories and AAIPharma Services. Sam headed up the business development group for WellSpring from its inception in 2001 to 2008. He returned to WellSpring in 2013 to revitalize the Pharma Services business and successfully completed its transformation into a leading pharmaceutical contract manufacturer. Sam also serves as secretary on the board of trustees for the Pharma & Biopharma Outsourcing Association.
Executive Director, quality and regulatory affairs
Sharon joined WellSpring with over 20 years’ experience in quality and regulatory affairs. Prior to joining WellSpring, Sharon worked as the Vice President, CMC and Quality Services at Mapi Group, a renowned consulting services company to pharmaceutical and biotech organizations in the fields of Regulatory Affairs, Quality Compliance, and Pharmacovigilance and Medical Information. Prior to that, Sharon worked at Otsuka Canada, Can Reg, SynX Pharma, and at the Canadian Blood Service. In her role as director, quality and regulatory affairs, Sharon oversees our quality and regulatory group which also includes our analytical, microbiology and stability groups.
Prior to joining WellSpring, David Watt had 20 years of experience in technical definition and evaluation of contract development and manufacturing projects both from provider and client perspectives at leading companies including Valeant, Medicis, Patheon and Syntex Pharmaceuticals. In his role as technical director, David oversees process development support and provides technical project management for technology transfer projects and process improvements.
Lonnie Barish, MBA
Executive Director, Business Development
Mr. Barish brings over 20 years of experience in sales, marketing and business development. Lonnie has worked directly for pharmaceutical/biotech and medical device companies along with the service provider sides of the pharmaceutical/medical device industries. Prior to joining WellSpring, Lonnie worked as executive director, North America at Nuvisan and business development director at CoreLab Partners and AAIPharma Services. Lonnie started his career at SmithKline Beecham Pharmaceuticals. In his role at WellSpring, Mr. Barish manages the sales, marketing, and business development functions representing WellSpring’s services to our customers in North America and worldwide.
Dara Caratao, PMP
Director, Program Management
Dara Caratao has been with WellSpring Pharma Services since 2008 and brings over 15 years of pharmaceutical project management experience for contract development and manufacturing projects. She worked at Patheon prior to joining Wellspring. In her role as director of program management, Dara directs planning and implementation of technology transfer projects.
Share the Risks and Rewards, Talk to WellSpring
Not every CMO has the flexibility that small and virtual biopharmaceutical companies need to move their product through clinical trials and into commercial production. If you have a product requiring esoteric equipment or a novel manufacturing process, you should know WellSpring has significant experience negotiating cost-sharing contracts with clients in order to acquire the equipment needed to facilitate production on any product type or form.